iKnowMed Ranked No. 1 EHR in Oncology/Hematology

Saturday, February 11, 2012 07:48 AM

iKnowMed Electronic Health Record (EHR) System, a product of McKesson Specialty Health and the US Oncology Network, has been named the highest ranked overall EHR vendor for oncology and hematology practices by the 2012 Black Book Rankings Survey. 

Black Book Rankings, a division of Brown-Wilson Group, is a full-service technology and services market research and opinion research company. The survey collected ballot results from more than 80,000 healthcare professionals in North America, including physicians and practice administrators, to find the top performing and most respected EHR vendors for 2012 in four categories—radiology, pathology, oncology and cardiology.

Out of 20 EHR vendors in the oncology category, iKnowMed received “overwhelming satisfaction and exceeds expectations” rankings in all 18 key performance areas and received the highest ranking in 12 of the 18 areas with an average score of 9.62 out of 10.

“Receiving top honors is significant because it... proves that an EHR developed by oncologists for oncologists really best supports their specialized needs,” said Mark A. Sitarik, M.D., medical director for iKnowMed.

iKnowMed is a web-based oncology-specific EHR that has achieved 2011/2012 Complete EHR Certification by an ONC-ATCB in accordance with Meaningful Use criteria. Clinical content includes point-of-care decision support with detailed cancer diagnosis and staging content, and a regimen library of more than 400 up-to-date cancer regimens. iKnowMed EHR supports clinical trial accruals for new and existing patients, provides access to level I pathways or evidence-based treatment guidelines, has integrated ePrescribing capabilities, a charge interface and has been proven to improve gross charge capture ranging from $35,000 to $86,000 per oncologist.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs